Search research articles
Contact Us
Filters
Showing results (531-540 of 1,050) with videos related to
Page
of 105
Sort By:
Advances in Neurology
|
January 1, 1988
The pathophysiology of cranial dystonia
A Berardelli, J C Rothwell, B L Day, et al.
Brain Research
|
October 25, 1991
Effects of 6-hydroxydopamine lesions of the nigrostriatal pathway on striatal serotonin innervation in adult rats
Y Takeuchi, T Sawada, S Blunt, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1997
Indices of oxidative stress in Parkinson's disease, Alzheimer's disease and dementia with Lewy bodies
A D Owen, A H Schapira, P Jenner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 7, 2000
Benign hereditary chorea--entity or syndrome?
A Schrag, N P Quinn, K P Bhatia, et al.
British Journal of Clinical Pharmacology
|
January 6, 2012
Bromocriptine and dopamine receptor stimulation
A G Debono, C D Marsden, P Asselman, et al.
The Journal of Pharmacy and Pharmacology
|
March 1, 1976
Circling behaviour produced by asymmetric medial raphé nuclei lesions in rats
B Costall, R J Naylor, C D Marsden, et al.
Brain : a Journal of Neurology
|
September 1, 1985
Pathophysiology of blepharospasm and oromandibular dystonia
A Berardelli, J C Rothwell, B L Day, et al.
Annals of Neurology
|
January 1, 1992
Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group
D T Dexter, P Jenner, A H Schapira, et al.
Biochemical Pharmacology
|
May 11, 1995
Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat--relationship to circling behaviour
K K Gnanalingham, A J Hunter, P Jenner, et al.
Psychopharmacology
|
February 1, 1995
The differential behavioural effects of benzazepine D1 dopamine agonists with varying efficacies, co-administered with quinpirole in primate and rodent models of Parkinson's disease
K K Gnanalingham, A J Hunter, P Jenner, et al.
Page
of 105
Search research articles
Search
Showing results (531-540 of 1,050) with videos related to
Sort By:
Page
of 105
Advances in Neurology
|
January 1, 1988
The pathophysiology of cranial dystonia
A Berardelli, J C Rothwell, B L Day, et al.
Brain Research
|
October 25, 1991
Effects of 6-hydroxydopamine lesions of the nigrostriatal pathway on striatal serotonin innervation in adult rats
Y Takeuchi, T Sawada, S Blunt, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1997
Indices of oxidative stress in Parkinson's disease, Alzheimer's disease and dementia with Lewy bodies
A D Owen, A H Schapira, P Jenner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 7, 2000
Benign hereditary chorea--entity or syndrome?
A Schrag, N P Quinn, K P Bhatia, et al.
British Journal of Clinical Pharmacology
|
January 6, 2012
Bromocriptine and dopamine receptor stimulation
A G Debono, C D Marsden, P Asselman, et al.
The Journal of Pharmacy and Pharmacology
|
March 1, 1976
Circling behaviour produced by asymmetric medial raphé nuclei lesions in rats
B Costall, R J Naylor, C D Marsden, et al.
Brain : a Journal of Neurology
|
September 1, 1985
Pathophysiology of blepharospasm and oromandibular dystonia
A Berardelli, J C Rothwell, B L Day, et al.
Annals of Neurology
|
January 1, 1992
Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group
D T Dexter, P Jenner, A H Schapira, et al.
Biochemical Pharmacology
|
May 11, 1995
Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat--relationship to circling behaviour
K K Gnanalingham, A J Hunter, P Jenner, et al.
Psychopharmacology
|
February 1, 1995
The differential behavioural effects of benzazepine D1 dopamine agonists with varying efficacies, co-administered with quinpirole in primate and rodent models of Parkinson's disease
K K Gnanalingham, A J Hunter, P Jenner, et al.
Page
of 105